Prostate Cancer

The Pharmacy Times® Prostate Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that occurs in the prostate.

Latest News

Image Credit: © Phushutter - stock.adobe.com
Apalutamide Demonstrates Efficacy After Prostate-Directed Local Therapy for nmCRPC

October 29th 2024

Apalutamide is a hormone therapy indicated for men with nonmetastatic castration-resistant prostate cancer (nmCRPC).

Human prostate cancer cells.
FDA Approves Diagnostics for Olaparib, Abiraterone Combination Therapy in Patients With BRCA-Mutated mCRPC

September 4th 2024

Prostate Cancer Diagnosis FDA | Image Credit: kenchiro168 - stock.adobe.com
FDA Grants Fast Track Designation to 64Cu-SAR-bisPSMA for Prostate Cancer Diagnosis

August 26th 2024

Image Credit: © Jo Panuwat D - stock.adobe.com
FoundationOne Liquid CDx Receives FDA Approval as a Diagnostic Tool for Patients With BRCA-Mutated mCRPC

July 2nd 2024

Man Hands holding blue ribbon over blue sky, Prostate Cancer Awareness, November blue, Movember Men health awareness - Image credit: SewcreamStudio | stock.adobe.com
FDA Grants Fast Track Designation to SYNC-T SV-102 for Metastatic Castration-Resistant Prostate Cancer

July 1st 2024

More News